Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-2 of 2 for cervical segment:7470538

Written Answers — Department of Health: Medicinal Products Availability (29 May 2019)

Louise O'Reilly: 104. To ask the Minister for Health if pembrolizumab has received marketing authorisation here and in the EU, respectively, for the treatment of cervical and colorectal cancer. [22941/19]

Written Answers — Department of Health: Medicinal Products Availability (29 May 2019)

Simon Harris: ...the EU for a number of indications and is reimbursed by the HSE for some of those indications. However, pembrolizumab does not have marketing authorisation in Ireland or the EU for the treatment of cervical or colorectal cancer. It should be noted clinical trials for various immunotherapies, including pembrolizumab, are ongoing globally for a range of other possible indications, which...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person